Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

J Li, JYS Lim, JQ Eu, AKMH Chan, BC Goh… - Antioxidants & Redox …, 2024 - liebertpub.com
Significance: Reactive oxygen species (ROS) are generated during mitochondrial oxidative
metabolism, and are tightly controlled through homeostatic mechanisms to maintain …

[HTML][HTML] Thioredoxin (Trx): A redox target and modulator of cellular senescence and aging-related diseases

B Yang, Y Lin, Y Huang, YQ Shen, Q Chen - Redox Biology, 2024 - Elsevier
Thioredoxin (Trx) is a compact redox-regulatory protein that modulates cellular redox state
by reducing oxidized proteins. Trx exhibits dual functionality as an antioxidant and a cofactor …

Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT …

C Deben, LF Boullosa, FR Fortes… - Journal of Experimental …, 2024 - Springer
Background This study explores the repurposing of Auranofin (AF), an anti-rheumatic drug,
for treating non-small cell lung cancer (NSCLC) adenocarcinoma and pancreatic ductal …

NLRP4 renders pancreatic cancer resistant to olaparib through promotion of the DNA damage response and ROS-induced autophagy

M Xiao, J Yang, M Dong, X Mao, H Pan, Y Lei… - Cell Death & …, 2024 - nature.com
Olaparib has been approved as a therapeutic option for metastatic pancreatic ductal
adenocarcinoma patients with BRCA1/2 mutations. However, a significant majority of …

[HTML][HTML] Ferroptosis in lung cancer: dual role, multi-level regulation, and new therapeutic strategies

Y Li, X Li, J Li - Frontiers in Oncology, 2024 - frontiersin.org
Lung cancer is a highly prevalent malignant tumor worldwide, with high incidence and death
rates. Recently, there has been increasing recognition of the role of ferroptosis, a unique cell …

Selenization of Small Molecule Drugs: A New Player on the Board

C Morán-Serradilla, D Plano, C Sanmartín… - Journal of Medicinal …, 2024 - ACS Publications
There is an urgent need to develop safer and more effective modalities for the treatment of a
wide range of pathologies due to the increasing rates of drug resistance, undesired side …

Combined auranofin and celecoxib suppresses the local progression and pulmonary metastases of osteosarcoma in vivo

H Kinoshita, S Kinoshita, H Kamoda… - Anticancer …, 2024 - ar.iiarjournals.org
Background/Aim: Osteosarcoma (OS) is a rare malignant tumor with a poor survival rate. Our
previous study reported that auranofin (AUR), a thioredoxin reductase inhibitor, suppresses …

[HTML][HTML] Investigation of Stabilized Amorphous Solid Dispersions to Improve Oral Olaparib Absorption

T Yun, S Lee, S Yun, D Cho, K Bang, K Kim - Pharmaceutics, 2024 - mdpi.com
In this study, we investigated the formulation of stable solid dispersions to enhance the
bioavailability of olaparib (OLA), a therapeutic agent for ovarian cancer and breast cancer …

Pristimerin inhibits thioredoxin reductase in the treatment of non-small cell lung cancer

Y Chu, Q Xu, X Zhou, Q Nie, X Yao, J Fang… - Acta Materia …, 2024 - scienceopen.com
Elevated cellular oxidative stress is a common marker of cancer cell dysregulation caused
by malignant transformation. Thioredoxin reductase (TrxR, encoded by TXNRD) is a crucial …

[HTML][HTML] 铁死亡在非小细胞肺癌中的作用及中药干预进展

GUO Xiaoqi, W Tianqi, XIA Jinchan… - Chinese Journal of …, 2024 - ncbi.nlm.nih.gov
非小细胞肺癌( non-small cell lung cancer, NSCLC) 是全球发病率和死亡率较高的恶性肿瘤之
一。 铁死亡是铁依赖性活性氧( reactive oxygen species, ROS) 异常堆积导致脂质过氧化而 …